Celecoxib (SC-58635) is a potent, selective COX-2 inhibitor. It affects COX-2/PGE2, PI3K/AKT, and NF-κB signaling pathways by blocking COX-2 enzymatic activity and reducing PGE2 production, thereby inhibiting cancer cell proliferation, migration, and angiogenesis, and promoting apoptosis.
Celecoxib (SC-58635) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Celecoxib (SC-58635) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.
Jump to
- Celecoxib (SC-58635) Mechanism of Action: COX-2 Inhibition in Cancer Cells Research
- Celecoxib (SC-58635) Clinical Trials
- Celecoxib (SC-58635) Working Concentration | Cell Culture | Treatment
- Celecoxib (SC-58635) Solubility in DMSO
- Celecoxib (SC-58635) Stock Solution
- Celecoxib (SC-58635) Storage
- Celecoxib (SC-58635) Stability
- Celecoxib (SC-58635) Combination Database
- Celecoxib (SC-58635) Molecular Weight
- Celecoxib (SC-58635) SMILES
- Celecoxib (SC-58635) CAS Number
- Celecoxib (SC-58635) Chemical Structure (2D and 3D)
- Celecoxib (SC-58635) APExBIO (A1664)? Try a better option.
- Celecoxib (SC-58635) Sigma (PHR1683)? Try a better option.
- Celecoxib (SC-58635) MedChemExpress (HY-14398)? Try a better option.
- Celecoxib (SC-58635) Cayman (10008672)? Try a better option.
- Celecoxib (SC-58635) SDS｜MSDS